| Literature DB >> 25600284 |
Debora Jančatová1, Karol Zeleník2, Pavel Komínek3, Petr Matoušek3.
Abstract
Cogan's syndrome is a rare chronic vasculitis, characterized in its typical form by progressive sensorineural bilateral hearing loss, vestibular symptoms and non-syphilitic interstitial keratitis. Only a few cases have been reported in children, most of whom have been diagnosed with the typical form. Early diagnosis and treatment are crucial to ensure a favorable prognosis. Systemic treatment usually begins with high dosage corticosteroids. In case the initial treatment fails, other immunosuppressive drugs are used (cyclophosphamide, methotrexate, cyclosporine A and azathioprine). Additional treatment possibilities, such as plasmapheresis, TNF-alpha blockers (etanercept and infliximab), rituximab, tocilizumab and mycophenolate mofetil have been described over the past few years.Entities:
Keywords: Cogan's syndrome; Corticosteroids; Immunosuppressive therapy; Interstitial keratitis; Sensorineural hearing loss; Vertigo
Mesh:
Substances:
Year: 2015 PMID: 25600284 DOI: 10.1016/j.ijporl.2014.12.028
Source DB: PubMed Journal: Int J Pediatr Otorhinolaryngol ISSN: 0165-5876 Impact factor: 1.675